In the realm of peripheral artery disease, particularly infrapopliteal artery disease, the quest for effective treatment options has been ongoing. A recent study, published in the New England Journal of Medicine on October 25, 2023, sheds light on a promising approach that could significantly impact the management of chronic limb-threatening ischemia (CLTI) due to infrapopliteal... Continue Reading →